依普利酮价格贵吗？

A new generation of selective aldosterone antagonist (Inspra) was developed by Pfizer/Pharmacia. The outstanding advantage of eplerenone is that it can treat severe hypertension that cannot be controlled by a combination of multiple antihypertensive drugs. The addition of eplerenone can significantly reduce blood pressure, especially the decrease in systolic blood pressure. For patients with severe heart failure and myocardial infarction, eplerenone combined with angiotensin-converting enzyme inhibitors (ACEI) and beta-blockers can improve quality of life and reduce mortality.

The initial dose of eplerenone (Inspra) for the treatment of congestive heart failure is 25 mg orally once daily; increase to target dose within four weeks as tolerated by the patient. The target dose is 50 mg orally once daily.

When treating adult patients with hypertension, eplerenone (Inspra) can be used alone or in combination with other antihypertensive drugs. It is administered orally. The initial dose is 50 mg, once a day; the maintenance dose is 50 mg, 1-2 times a day. The maximum dose is 100 mg/day and patients should not overdose.

In 2002, eplerenone was approved for marketing in the United States for the first time. The price of the original drug in the United States is relatively high, and long-term medication is still a considerable expense for many patients. As Indian drugs continue to enter the attention of domestic patients, many patients have asked whether there is eplerenone produced in India? Is it expensive?

The Indian version (Inspra) is produced by Lupine Pharmaceuticals in India. The price is much lower than the original drug in the United States, and the effect is almost the same. The Indian version of eplerenone (Inspra) is available in 50mg*100 tablets and costs around $500. Due to the influence of exchange rates and other factors, the price is not fixed. Please consult Medical Travel for specific prices.

Recommended related hot articles: /newsDetail/72999.html